What's new

EMEA-003233-PIP01-22

EMEA-003233-PIP01-22

Feb 13, 2025 - 14:11
 0
EMEA-003233-PIP01-22
EMEA-003233-PIP01-22
Read More

Tags:

Previous Article

From 1920s Thinking to Digital Autonomy: After 100 Years, It’s Time To Rethink H...

Next Article

EMA Veterinary Innovation Day, Online, European Medicines Agency, Amsterdam, the...

Related Posts

Opinion/decision on a Paediatric investigation plan (PIP): Agamree, Vamorolone, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Other, PIP number: P/0515/2023

Opinion/decision on a Paediatric investigation plan (PI...

Feb 14, 2025  0

Human medicines European public assessment report (EPAR): Blitzima, rituximab, Date of authorisation: 13/07/2017, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

Human medicines European public assessment report (EPAR): Cimzia, certolizumab pegol, Date of authorisation: 01/10/2009, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 18, 2025  0